Intravenous Laser Therapy
Intravenous Laser Therapy
Studies show stabilization and energizing effects and improvement of laboratory values and many other positive effects on often intractable diseases
Intravascular laser blood irradiation was performed for the first time about 25 years ago in the former Soviet Union. Laser light was introduced directly into the flowing blood. Previously, in-vitro studies have shown that biological Soft laser irradiation of white blood cells trigger a variety of positive effects, in particular expression of immunoglobulins, interferons and interleukins, which are of particular importance. After introduction of the process, numerous studies were published that showed additional effects on various metabolic processes.
Weber Medical achieved approval for its intravascular laser blood irradiation apparatus in 2005 this was in part funded by a program titled Biophotonics II of the state government of Lower Saxony. Following this, Weber Medical treatment was used in Germany for the first time on patients in clinical trials. In our own studies, the results from the predominantly Russian literature are largely confirmed. We found in almost all patients a general stabilizing and energizing as well as many other positive effects in conditions like chronic liver diseases, diabetes mellitus, lipid disorders, and various other diseases. This opens new therapy options in the treatment of systemic disorders of the metabolism and immune system.
General Effects
Significant improvement in overall performance
Improvement in sleep and vigilance
Positive effect on the general mood
Reduction of drug consumption
Special Effects
Optimization of the diabetic metabolic state
stat incomparable influence of hypercholesterolemia
significant reduction of pathologically elevated liver values
Reduction in frequency of relapses in chronic inflammatory bowel disease
Improvement in general health status and mobility in MS disease
positive influence on intractable pain syndromes
positive influence of tinnitus
Reduction of antihypertensive medication for severe hypertension
positive influence of maculopathy
Increase of ATP with laser irradiation (632 nm) of HeLa-cell culture
Areas of application:
Diabetes mellitus
Chronic liver and kidney diseases
Dyslipidemia
Heart disease
Chronic pain syndromes
Allergies and eczema
Performance enhancement in sport
Polyneuropathies
Fibromyalgia
Rheumatism
Hypertension
Tinnitus
Macular Degeneration
Multiple Sclerosis
Depression
Burn-out syndrome
CFS (chronic fatigue syndrome)
Lyme disease
Intravenous laser therapy with blue laser